17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GUCY1A1 mRNA CTD PMID:12655037 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol deficiency results in decreased expression of GUCY1A1 mRNA, Estradiol deficiency results in decreased expression of GUCY1A1 protein CTD PMID:18787021 17beta-estradiol increases expression ISO RGD:68653 6480464 Estradiol results in increased expression of GUCY1A1 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO RGD:68653 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of GUCY1A1 mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:68653 6480464 Dihydrotestosterone results in increased expression of GUCY1A1 mRNA CTD PMID:29581250 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions ISO RGD:68653 6480464 1H-(1 more ... CTD PMID:11744065 , PMID:22171090 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one increases degradation EXP 6480464 1H-(1 more ... CTD PMID:19466990 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions EXP 6480464 1H-(1 more ... CTD PMID:12495780 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68654 6480464 Tetrachlorodibenzodioxin affects the expression of GUCY1A1 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GUCY1A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:68654 6480464 Tetrachlorodibenzodioxin results in increased expression of GUCY1A1 mRNA CTD PMID:28213091 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:68653 6480464 2 more ... CTD PMID:26705709 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of GUCY1A1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:68653 6480464 beta-methylcholine affects the expression of GUCY1A1 mRNA CTD PMID:21179406 3',5'-cyclic GMP increases abundance ISO RGD:68653 6480464 GUCY1A1 gene mutant form results in increased abundance of Cyclic GMP CTD PMID:25373139 3',5'-cyclic GMP multiple interactions ISO RGD:68653 6480464 [GUCY1A1 protein binds to GUCY1B1 protein] which results in increased chemical synthesis of Cyclic GMP more ... CTD PMID:22171090 , PMID:24213632 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:68653 6480464 tetrabromobisphenol A results in increased expression of GUCY1A1 mRNA CTD PMID:35321852 3,4-methylenedioxymethamphetamine increases expression ISO RGD:68654 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GUCY1A1 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:68654 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of GUCY1A1 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GUCY1A1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:68654 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GUCY1A1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:68654 6480464 Fenretinide results in decreased expression of GUCY1A1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GUCY1A1 mRNA CTD PMID:24780913 7H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of GUCY1A1 protein CTD PMID:17339839 9H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of GUCY1A1 protein CTD PMID:17339839 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of GUCY1A1 protein CTD PMID:19903525 all-trans-retinoic acid increases expression ISO RGD:68653 6480464 Tretinoin results in increased expression of GUCY1A1 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:68653 6480464 Tretinoin results in decreased expression of GUCY1A1 mRNA CTD PMID:23724009 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of GUCY1A1 protein CTD PMID:16517024 antirheumatic drug increases expression ISO RGD:68653 6480464 Antirheumatic Agents results in increased expression of GUCY1A1 mRNA CTD PMID:24449571 apocynin increases expression EXP 6480464 acetovanillone results in increased expression of GUCY1A1 protein CTD PMID:25217652 aristolochic acid A decreases expression ISO RGD:68653 6480464 aristolochic acid I results in decreased expression of GUCY1A1 mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO RGD:68653 6480464 [4-(2-(5 more ... CTD PMID:34480604 atrazine decreases expression ISO RGD:68653 6480464 Atrazine results in decreased expression of GUCY1A1 mRNA CTD PMID:22378314 benzo[a]pyrene increases mutagenesis ISO RGD:68653 6480464 Benzo(a)pyrene results in increased mutagenesis of GUCY1A1 gene CTD PMID:25435355 benzo[a]pyrene increases methylation ISO RGD:68653 6480464 Benzo(a)pyrene results in increased methylation of GUCY1A1 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:68653 6480464 Benzo(a)pyrene results in decreased methylation of GUCY1A1 exon, Benzo(a)pyrene results in decreased methylation of GUCY1A1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:68654 6480464 Benzo(a)pyrene results in increased expression of GUCY1A1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GUCY1A1 mRNA CTD PMID:21839799 bisphenol A increases expression ISO RGD:68654 6480464 bisphenol A results in increased expression of GUCY1A1 mRNA CTD PMID:26063408 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GUCY1A1 mRNA CTD PMID:30816183 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GUCY1A1 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:68654 6480464 bisphenol F results in increased expression of GUCY1A1 mRNA CTD PMID:30951980 calcitriol increases expression ISO RGD:68653 6480464 Calcitriol results in increased expression of GUCY1A1 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:68654 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of GUCY1A1 mRNA CTD PMID:19395590 CHIR 99021 multiple interactions ISO RGD:68653 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of GUCY1A1 mRNA CTD PMID:23125180 chloroprene decreases expression ISO RGD:68654 6480464 Chloroprene results in decreased expression of GUCY1A1 mRNA CTD PMID:23125180 cinaciguat multiple interactions ISO RGD:68653 6480464 [BAY 58-2667 co-treated with 1H-(1 more ... CTD PMID:22171090 cinaciguat multiple interactions EXP 6480464 1H-(1 more ... CTD PMID:19466990 clobetasol increases expression ISO RGD:68654 6480464 Clobetasol results in increased expression of GUCY1A1 mRNA CTD PMID:27462272 cocaine increases expression EXP 6480464 Cocaine results in increased expression of GUCY1A1 mRNA CTD PMID:17898221 copper atom multiple interactions ISO RGD:68653 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GUCY1A1 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of GUCY1A1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:68653 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GUCY1A1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of GUCY1A1 mRNA CTD PMID:30556269 cortisol multiple interactions ISO RGD:68653 6480464 [4-(2-(5 more ... CTD PMID:34480604 crocidolite asbestos decreases expression ISO RGD:68654 6480464 Asbestos, Crocidolite results in decreased expression of GUCY1A1 mRNA CTD PMID:29279043 cyanocob(III)alamin multiple interactions ISO RGD:68653 6480464 3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3 more ... CTD PMID:22171090 cyclosporin A decreases expression ISO RGD:68653 6480464 Cyclosporine results in decreased expression of GUCY1A1 mRNA CTD PMID:20106945 cytarabine decreases expression ISO RGD:68653 6480464 Cytarabine results in decreased expression of GUCY1A1 mRNA CTD PMID:21198554 diethyl malate affects expression ISO RGD:68654 6480464 diethyl malate affects the expression of GUCY1A1 mRNA CTD PMID:24814887 dioxygen multiple interactions ISO RGD:68654 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GUCY1A1 mRNA CTD PMID:30529165 disodium selenite decreases expression ISO RGD:68653 6480464 Sodium Selenite results in decreased expression of GUCY1A1 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of GUCY1A1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:68653 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:68653 6480464 Doxorubicin results in decreased expression of GUCY1A1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GUCY1A1 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:68653 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCY1A1 mRNA CTD PMID:27188386 ethanol affects splicing ISO RGD:68654 6480464 Ethanol affects the splicing of GUCY1A1 mRNA CTD PMID:30319688 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of GUCY1A1 mRNA CTD PMID:30307764 ferroheme b multiple interactions EXP 6480464 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]] more ... CTD PMID:19466990 folic acid decreases expression ISO RGD:68653 6480464 Folic Acid results in decreased expression of GUCY1A1 mRNA CTD PMID:21867686 formaldehyde decreases expression ISO RGD:68653 6480464 Formaldehyde results in decreased expression of GUCY1A1 mRNA CTD PMID:23649840 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of GUCY1A1 mRNA CTD PMID:24136188 GTP multiple interactions ISO RGD:68653 6480464 [dicyanocobinamide results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]] which results in increased metabolism of Guanosine Triphosphate CTD PMID:22171090 heme b multiple interactions EXP 6480464 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]] more ... CTD PMID:19466990 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of GUCY1A1 mRNA, Hydrogen Peroxide results in decreased expression of GUCY1A1 protein CTD PMID:17339839 hydroxocobalamin multiple interactions ISO RGD:68653 6480464 Hydroxocobalamin results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] CTD PMID:22171090 isoflavones decreases expression EXP 6480464 Isoflavones results in decreased expression of GUCY1A1 mRNA CTD PMID:19025659 L-ascorbic acid multiple interactions ISO RGD:68653 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GUCY1A1 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:68653 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GUCY1A1 mRNA CTD PMID:34480604 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of GUCY1A1 mRNA CTD PMID:11729227 lipopolysaccharide multiple interactions ISO RGD:68654 6480464 ESR1 protein affects the reaction [Lipopolysaccharides affects the expression of GUCY1A1 mRNA], ESR1 protein affects the reaction [Lipopolysaccharides affects the expression of GUCY1A1 protein] CTD PMID:17158209 lipopolysaccharide increases expression ISO RGD:68653 6480464 Lipopolysaccharides results in increased expression of GUCY1A1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:68653 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GUCY1A1 mRNA] CTD PMID:35811015 manganese atom multiple interactions ISO RGD:68653 6480464 Manganese results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] CTD PMID:22171090 manganese(0) multiple interactions ISO RGD:68653 6480464 Manganese results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] CTD PMID:22171090 menadione decreases expression EXP 6480464 Vitamin K 3 results in decreased expression of GUCY1A1 protein CTD PMID:17339839 methylseleninic acid affects expression ISO RGD:68653 6480464 methylselenic acid affects the expression of GUCY1A1 mRNA CTD PMID:14617803 methylseleninic acid decreases expression ISO RGD:68653 6480464 methylselenic acid results in decreased expression of GUCY1A1 mRNA CTD PMID:16020662 , PMID:18548127 methylseleninic acid multiple interactions ISO RGD:68653 6480464 AR protein inhibits the reaction [methylselenic acid results in decreased expression of GUCY1A1 mRNA] CTD PMID:16020662 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:68654 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of GUCY1A1 mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:68654 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of GUCY1A1 mRNA CTD PMID:25566086 nickel atom decreases expression ISO RGD:68653 6480464 Nickel results in decreased expression of GUCY1A1 mRNA CTD PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of GUCY1A1 mRNA CTD PMID:24136188 nitric oxide increases response to substance ISO RGD:68653 6480464 GUCY1A1 gene mutant form results in increased susceptibility to Nitric Oxide CTD PMID:25373139 nitric oxide multiple interactions ISO RGD:68653 6480464 1H-(1 more ... CTD PMID:11744065 nitroglycerin increases expression EXP 6480464 Nitroglycerin results in increased expression of GUCY1A1 mRNA, Nitroglycerin results in increased expression of GUCY1A1 protein CTD PMID:11331261 nitroprusside multiple interactions EXP 6480464 1H-(1 more ... CTD PMID:12495780 , PMID:17050951 NONOate(1-) multiple interactions ISO RGD:68653 6480464 1 more ... CTD PMID:22171090 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GUCY1A1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:68654 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GUCY1A1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GUCY1A1 mRNA CTD PMID:34911549 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of GUCY1A1 mRNA CTD PMID:27638505 panobinostat multiple interactions ISO RGD:68653 6480464 (+)-JQ1 compound promotes the reaction [panobinostat affects the expression of GUCY1A1 mRNA], panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of GUCY1A1 mRNA] CTD PMID:26733615 panobinostat affects expression ISO RGD:68653 6480464 panobinostat affects the expression of GUCY1A1 mRNA CTD PMID:26733615 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GUCY1A1 mRNA CTD PMID:20388547 pentachlorophenol increases expression ISO RGD:68654 6480464 Pentachlorophenol results in increased expression of GUCY1A1 mRNA CTD PMID:23892564 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of GUCY1A1 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:68654 6480464 Phenobarbital affects the expression of GUCY1A1 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:68653 6480464 Phenylmercuric Acetate results in decreased expression of GUCY1A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:68653 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCY1A1 mRNA CTD PMID:27188386 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of GUCY1A1 mRNA CTD PMID:15059925 pioglitazone multiple interactions ISO RGD:68654 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GUCY1A1 mRNA CTD PMID:27935865 pirinixic acid multiple interactions ISO RGD:68653 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GUCY1A1 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of GUCY1A1 mRNA CTD PMID:19162173 potassium dichromate decreases expression ISO RGD:68654 6480464 Potassium Dichromate results in decreased expression of GUCY1A1 mRNA CTD PMID:23608068 potassium hexacyanoferrate(3-) multiple interactions ISO RGD:68653 6480464 potassium ferricyanide inhibits the reaction [1, 1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]] CTD PMID:22171090 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of GUCY1A1 mRNA CTD PMID:20726854 protoporphyrin multiple interactions ISO RGD:68653 6480464 Polysorbates promotes the reaction [protoporphyrin IX results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]], protoporphyrin IX results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] CTD PMID:22171090 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68653 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GUCY1A1 mRNA] CTD PMID:35811015 S-nitrosoglutathione multiple interactions ISO RGD:68653 6480464 GUCY1A1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased abundance of Cyclic GMP] CTD PMID:24213632 SB 431542 multiple interactions ISO RGD:68653 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 sodium arsenate increases expression ISO RGD:68654 6480464 sodium arsenate results in increased expression of GUCY1A1 mRNA CTD PMID:21795629 Soman decreases expression EXP 6480464 Soman results in decreased expression of GUCY1A1 mRNA CTD PMID:19281266 taurine decreases expression ISO RGD:68653 6480464 Taurine results in decreased expression of GUCY1A1 mRNA CTD PMID:16579726 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GUCY1A1 mRNA CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:68654 6480464 titanium dioxide results in decreased expression of GUCY1A1 mRNA CTD PMID:23557971 toluene affects expression EXP 6480464 Toluene affects the expression of GUCY1A1 mRNA CTD PMID:21827849 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GUCY1A1 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of GUCY1A1 mRNA CTD PMID:33387578 tunicamycin increases expression ISO RGD:68654 6480464 Tunicamycin results in increased expression of GUCY1A1 mRNA CTD PMID:17127020 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GUCY1A1 mRNA CTD PMID:23665938 valproic acid multiple interactions ISO RGD:68653 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GUCY1A1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:68653 6480464 Valproic Acid results in increased expression of GUCY1A1 mRNA CTD PMID:23179753 more ... vancomycin decreases expression ISO RGD:68654 6480464 Vancomycin results in decreased expression of GUCY1A1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of GUCY1A1 mRNA CTD PMID:20566332 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of GUCY1A1 mRNA CTD PMID:23034163 XAV939 multiple interactions ISO RGD:68653 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GUCY1A1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GUCY1A1 mRNA CTD PMID:34480604 zinc protoporphyrin multiple interactions EXP 6480464 zinc protoporphyrin inhibits the reaction [5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]], zinc protoporphyrin inhibits the reaction [BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]] CTD PMID:19466990